Clinical Trials List
2025-12-05 - 2032-12-31
Phase III
Not yet recruiting3
ICD-10E85.0
Non-neuropathic heredofamilial amyloidosis
ICD-10E85.1
Neuropathic heredofamilial amyloidosis
ICD-10E85.2
Heredofamilial amyloidosis, unspecified
ICD-10E85.3
Secondary systemic amyloidosis
ICD-10E85.4
Organ-limited amyloidosis
ICD-10E85.8
Other amyloidosis
ICD-10E85.9
Amyloidosis, unspecified
ICD-9277.3
Amyloidosis
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 蕭丞宗 Division of Neurology
- Wen-Chung Yu Division of Cardiovascular Diseases
- 季康揚 Division of Neurology
- 邱睿涵 Division of Radiology
- 張富邦 Division of Others
- 郭泠 Division of Cardiovascular Diseases
- Kon-Ping Lin Division of Neurology
- 胡蓮欣 Division of Nuclear Medicine
- Yi-Chu Liao Division of Neurology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YEN-HUNG LIN Division of General Internal Medicine
- HSUEH-WEN HSUEH Division of Neurology
- SUNG-TSANG HSIEH Division of Neurology
- Ming-Jen Lee Division of Neurology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
250 participants
